EXEL vs FDX · P/E 17, rev $628.7M vs P/E 18, rev $94.72B
Exelixis Inc (EXEL) versus FedEx Corporation (FDX) — a side-by-side from cached financials, not a winner call.
Exelixis Inc (EXEL) is a biotechnology company listed on US.
FedEx Corporation (FDX) is a integrated freight & logistics company listed on US.
Latest reported EXEL revenue for 2026-07-03 was $628.7M. Net income was $212.1M. Revenue was up 2.9% from 2026-04-03 to 2026-07-03. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
Latest reported FDX revenue for 2026-05-31 was $94.72B. Net income was $4.43B. Revenue was up 7.7% from 2025-05-31 to 2026-05-31. FDX currently screens at market cap $78.98B and trailing P/E 17.7.
EXEL currently screens at market cap $12.69B and trailing P/E 16.7. FDX currently screens at market cap $78.98B and trailing P/E 17.7.
Not investment advice. Open the EXEL and FDX stock pages for the full models.
Not investment advice.